Consumers

The FTC’s investigation into the business practices of PBMs could expose the outsized influence PBMs have on access…

Prescryptive Health partnered with Eli Lilly and Company on a new subscription model to help lower costs for…

Prescryptive Health has partnered with Eli Lilly to create a subscription-based insulin program for employers that aims to…

The new financial model aims to provide price transparency while encouraging medication adherence.

Prescryptive CEO, Chris Blackley, joins the Healthcare Americana podcast to discuss the root of the prescription drug pricing…

Our CEO Chris Blackley writes in MedCity News about the FTC’s new probe into the big pharmacy benefit…

As Deb Gordon writes in Forbes about our Pharmacy Trends survey, “…90% of survey respondents said they would appreciate…

85% of Consumers Don’t Know a Drug’s Price Before the Checkout Counter

Owning your pharmacy benefits data is a must. In her latest Benefits PRO article, Andrea Pickett, Prescryptive’s Chief…

Hear what our co-founder and CEO, Chris Blackley, has to say about the recent FTC probe into the…

Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies – MedCity News

With inflation and other global factors increasing the risk of recession, savvy IT pros are reconsidering their approaches…